Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

New understanding and treatments for hair loss are improving, but more research is needed.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Treatment with specific medications and supplements improved skin condition and hair regrowth in an Akita with sebaceous adenitis.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

Dianabol boosts muscle growth but has serious health risks and legal issues.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.